Brii Biosciences Ltd - 31 Dec 2024 SCHEDULE 13G/A Report for AN2 THERAPEUTICS, INC. Common Stock, $0.00001 par value per share (ANTX)

Filing Manager: Brii Biosciences Ltd
Reporting Manager: Brii Biosciences Limited
Security: AN2 THERAPEUTICS, INC. Common Stock, $0.00001 par value per share
Symbol: ANTX
Shares outstanding: 29.9M shares
Disclosed Ownership: 927K shares
Ownership: 3.1%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:30:17 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Brii Biosciences Limited	3.1%	927K	927K	0	/s/ Ankang Li	Ankang Li, Executive Director, Chief Strategy and Financial Officer